P53 Status Influences the Anti-proliferative Effect Induced by IFITM1 Inhibition in Estrogen Receptor-positive Breast Cancer Cells

Der Sheng Sun(Catholic University of Korea), Hye Sung Won(The Catholic University of Korea Uijeongbu St. Mary's Hospital)

Cancer Genomics & Proteomics

August 27, 2024

10.21873/cgp.20468

Cited by 0

Related Papers

Inhibition of β-Catenin to Overcome Endocrine Resistance in Tamoxifen-Resistant Breast Cancer Cell Line

|PLoS ONE|2016|35

IFITM1 Influences Natural Killer Cell-Mediated Cytotoxicity by Modulation of HLA class I Expression in Triple-Negative Breast Cancer Cells

|Cancer Research and Treatment|2025|0